SOPHiA GENETICS is excited to be a part of the BioData World Congress 2022 annual meeting, held in-person November 8-10 in Basel, Switzerland.
Throughout the congress, our experts will be pleased to meet you at booth #99 to explore how we can help you access high-quality, real-world multimodal data in real-time.
Join us for our panel discussion on Wednesday 09 November at 12:05pm
“Hope or Hype?: The Importance of Multimodal Data Integration to Advance Precision Medicine”
Our panelists will debate the importance of combining a diversity of data modalities for the longitudinal follow-up of patients from diagnosis to treatment to outcomes, to develop a better understanding of the patient journey and to identify patient subpopulations for precision medicine.
The panel discussion will focus on:
- The increased need for a validated platform that integrates multimodal data
- The role of AI and real-world data in clinical practice
- The major challenges related to applying AI in healthcare
Panelists
David Dellamonica, MBA – Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca
Michael G. Frank, MBA – Digital Ventures Lead, Memorial Sloan Kettering Cancer Center
Jacques Cadranel, MD, Oncologist, Pneumology Service – Sorbonne Université and AP-HP Hôpital Tenon Paris
Philippe Menu, MD, PhD, MBA – Chief Medical Officer, SOPHiA GENETICS
Moderator
Peter Casasanto, MBA – Chief BioPharma Officer, SOPHiA GENETICS
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
